DK1740163T3 - Flerfasepræparat til kontraception på basis af et naturligt østrogen - Google Patents

Flerfasepræparat til kontraception på basis af et naturligt østrogen

Info

Publication number: DK1740163T3
Authority: DK; Denmark
Prior art keywords: natural estrogen; multiphase preparation; contraception based; contraception; multiphase
Prior art date: 2004-04-20

Application number

DK05730867.8T

Other languages

English (en)

Other versions

DK1740163T4 (da

Inventor

Jan Endrikat

Bernd Duesterberg

Original Assignee

Bayer Schering Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-20

Filing date

2005-04-15

Publication date

2010-10-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1740163(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-04-15 Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag

2010-10-18 Application granted granted Critical

2010-10-18 Publication of DK1740163T3 publication Critical patent/DK1740163T3/da

2020-04-06 Publication of DK1740163T4 publication Critical patent/DK1740163T4/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Steroid Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)

DK05730867.8T 2004-04-20 2005-04-15 Flerfasepræparat til kontraception på basis af et naturligt østrogen DK1740163T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004019743A DE102004019743B4 (de)	2004-04-20	2004-04-20	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
PCT/EP2005/004022 WO2005102247A2 (de)	2004-04-20	2005-04-15	Mehrphasenpräparat zur kontrazeption auf der basis eines natürlichen estrogens

Publications (2)

Publication Number	Publication Date
DK1740163T3 true DK1740163T3 (da)	2010-10-18
DK1740163T4 DK1740163T4 (da)	2020-04-06

Family

ID=34979546

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05730867.8T DK1740163T4 (da)	2004-04-20	2005-04-15	Flerfasepræparat til kontraception på basis af et naturligt østrogen

Country Status (37)

Country	Link
US (3)	US8071577B2 (da)
EP (1)	EP1740163B2 (da)
JP (1)	JP4908399B2 (da)
KR (1)	KR20060134168A (da)
CN (1)	CN1946383B (da)
AR (2)	AR048830A1 (da)
AT (1)	ATE473734T1 (da)
AU (1)	AU2005235418C1 (da)
BR (1)	BRPI0510005A (da)
CA (1)	CA2561839C (da)
CR (1)	CR8695A (da)
CY (1)	CY1111292T1 (da)
DE (2)	DE102004019743B4 (da)
DK (1)	DK1740163T4 (da)
EA (1)	EA010313B1 (da)
EC (1)	ECSP067000A (da)
ES (1)	ES2348038T5 (da)
GT (1)	GT200500093A (da)
HR (1)	HRP20100513T4 (da)
IL (2)	IL178510A (da)
ME (1)	ME01183B (da)
MX (1)	MXPA06012213A (da)
MY (1)	MY143669A (da)
NO (1)	NO344098B1 (da)
NZ (1)	NZ550417A (da)
PA (1)	PA8630901A1 (da)
PE (1)	PE20060308A1 (da)
PL (1)	PL1740163T5 (da)
PT (1)	PT1740163E (da)
RS (1)	RS51434B2 (da)
SI (1)	SI1740163T2 (da)
SV (1)	SV2006002090A (da)
TW (1)	TWI351960B (da)
UA (1)	UA83915C2 (da)
UY (1)	UY28863A1 (da)
WO (1)	WO2005102247A2 (da)
ZA (1)	ZA200609594B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004019743B4 (de) *	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
EP1787649B1 (de) *	2005-10-13	2009-03-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption
ATE546144T1 (de) *	2005-10-13	2012-03-15	Bayer Pharma AG	Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysf unktionellen uterinen blutung in einheit mit einer oralen kontrazeption
US8153616B2 (en)	2005-10-17	2012-04-10	Bayer Pharma Aktiengesellschaft	Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
WO2007106264A2 (en) *	2006-03-02	2007-09-20	Warner Chilcott Company, Inc.	Extended cycle multiphasic oral contraceptive method
DE102006010329A1 (de) *	2006-03-06	2007-09-13	Höltge, Michael, Dipl.-Med.	Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron
EP1930010A1 (de) *	2006-10-20	2008-06-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US20090117183A1 (en) *	2007-11-05	2009-05-07	Sabine Fricke	Oral contraceptive containing a gestagen and an estrogen combined with pharmaceutically acceptable auxiliary agents and/or excipients, but not containing lactose, and method of making same
WO2012155091A1 (en) *	2011-05-11	2012-11-15	Kirax Corporation	Package for improved treatment of conditions

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4168068A (en)	1969-07-22	1971-01-28	Unisearch Limited	Improvements in or relating to oral contraceptives
US3639600A (en)	1969-08-28	1972-02-01	Upjohn Co	Process of establishing cyclicity in a human female
US3795734A (en)	1970-04-20	1974-03-05	American Home Prod	Cyclic regimen of hormone administration for contraception
US4066757A (en)	1973-03-26	1978-01-03	Ortho Pharmaceutical Corporation	Oral contraceptive regimen
DE2365103C3 (de)	1973-12-21	1980-08-28	Schering Ag, 1000 Berlin Und 4619 Bergkamen	V erwendung von Hormonen zur Kontrazeption
DE2431704A1 (de)	1974-07-02	1976-01-22	Asche Ag	Stufenkombinationspraeparate per kontrazeption
DE2645307A1 (de)	1976-10-05	1978-04-06	Schering Ag	Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
JPS6019734B2 (ja)	1977-05-12	1985-05-17	三共株式会社	安定なプロスタグランジンｅ類製剤の製法
US4272270A (en)	1979-04-04	1981-06-09	Petrochem Consultants, Inc.	Cryogenic recovery of liquid hydrocarbons from hydrogen-rich
NL8001593A (nl) *	1980-03-18	1981-10-16	Akzo Nv	Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4390531A (en)	1981-08-10	1983-06-28	Syntex Pharmaceuticals International Ltd.	Method of contraception using peak progestogen dosage
US4921843A (en)	1988-10-20	1990-05-01	Pasquale Samuel A	Contraception system and method
US4544554A (en)	1983-09-26	1985-10-01	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
US4530839A (en)	1983-09-26	1985-07-23	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
US4628051A (en)	1983-09-26	1986-12-09	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
US4616006A (en)	1983-09-26	1986-10-07	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
DE3341638A1 (de)	1983-11-17	1984-05-03	Hermann Dr.rer.nat. 8000 München Heßlinger	Dreiphasen-praeparat zur empfaengnisverhuetung aus ethinyloestradiol und lynestrenol
DE3347125A1 (de)	1983-12-22	1985-07-11	Schering AG, 1000 Berlin und 4709 Bergkamen	Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
AU581486B2 (en)	1985-12-30	1989-02-23	Warner-Lambert Company	Graduated estrogen contraceptive
DK174724B1 (da)	1986-07-15	2003-10-06	Wyeth Corp	Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CA2005933A1 (en)	1989-01-09	1990-07-09	Jesse Hipps, Sr.	Photohardenable composition containing five member aromatic group with imine moiety
IE71203B1 (en) *	1990-12-13	1997-02-12	Akzo Nv	Low estrogen oral contraceptives
DE4104385C1 (da)	1991-02-09	1992-08-13	Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4224534A1 (de)	1992-07-24	1994-01-27	Marika Dr Med Ehrlich	Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4308406C1 (de)	1993-03-12	1994-06-16	Jenapharm Gmbh	Kombinationspräparat zur Kontrazeption
DE4313926A1 (de) *	1993-04-28	1994-11-03	Jenapharm Gmbh	Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
DE4339934C2 (de)	1993-05-07	1995-05-24	Klaus Dr Med Umbreit	Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl)	1993-09-09	1995-04-03	Saturnus Ag	Preparaat voor substitutietherapie.
DE4344462C2 (de)	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE4429374C1 (de)	1994-08-12	1996-02-01	Jenapharm Gmbh	Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19525017A1 (de)	1995-06-28	1997-01-02	Schering Ag	Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19540253C2 (de)	1995-10-28	1998-06-04	Jenapharm Gmbh	Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
US20050032756A1 (en)	1995-10-28	2005-02-10	Michael Dittgen	Multistage preparation for contraception based on natural estrogens
EP0956024B1 (en)	1996-07-26	2004-07-21	Wyeth	Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen
DE69731092T2 (de)	1996-07-26	2005-02-10	Wyeth	Orales contrazeptivum
ATE249222T1 (de) *	1996-07-26	2003-09-15	Wyeth Corp	Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
US6987101B1 (en)	1996-12-20	2006-01-17	Schering Aktiengesellschaft	Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
DE19654609A1 (de)	1996-12-20	1998-06-25	Schering Ag	Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder
US5898032A (en)	1997-06-23	1999-04-27	Medical College Of Hampton Roads	Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6312772B1 (en) *	1997-10-20	2001-11-06	Hoechst Celanese Corporation	Multilayer laminate formed from a substantially stretched non-molten wholly aromatic liquid crystalline polymer and non-polyester thermoplastic polymer
DE19908762A1 (de)	1999-02-18	2000-08-31	Jenapharm Gmbh	Verwendung von Dienogest in hoher Dosierung
DE10045380A1 (de)	2000-09-14	2002-04-04	Schering Ag	Verfahren zur Kontrazeption und dessen Darreichungsform
US6699820B2 (en)	2001-03-02	2004-03-02	Hartmut Ulrich Bielefeldt	Method for making a superconductor with enhanced current carrying capability
DE10294402D2 (de)	2001-09-29	2004-11-11	Solvay Pharm Gmbh	Estrogen-Gestagen Kombinationspräparat und Anwendung
EP1462106A1 (en)	2003-03-28	2004-09-29	Pantarhei Bioscience B.V.	Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
US20050032758A1 (en)	2003-06-25	2005-02-10	Ina Rudolph	Hormone replacement therapy and depression
DE102004019743B4 (de)	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
AU2005294269B2 (en)	2004-10-07	2011-07-28	Teva Women's Health, Inc.	Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
TW200726473A (en)	2005-06-28	2007-07-16	Wyeth Corp	Compositions and methods for treatment of cycle-related symptoms
EP1787649B1 (de)	2005-10-13	2009-03-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption
US8153616B2 (en)	2005-10-17	2012-04-10	Bayer Pharma Aktiengesellschaft	Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de)	2006-10-20	2008-06-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

2004
- 2004-04-20 DE DE102004019743A patent/DE102004019743B4/de not_active Expired - Fee Related
2005
- 2005-03-09 MY MYPI20050962A patent/MY143669A/en unknown
- 2005-03-25 TW TW094109222A patent/TWI351960B/zh active
- 2005-04-15 DK DK05730867.8T patent/DK1740163T4/da active
- 2005-04-15 MX MXPA06012213A patent/MXPA06012213A/es active IP Right Grant
- 2005-04-15 BR BRPI0510005-4A patent/BRPI0510005A/pt not_active Application Discontinuation
- 2005-04-15 HR HRP20100513TT patent/HRP20100513T4/hr unknown
- 2005-04-15 CA CA002561839A patent/CA2561839C/en not_active Expired - Lifetime
- 2005-04-15 ME MEP-2010-149A patent/ME01183B/me unknown
- 2005-04-15 WO PCT/EP2005/004022 patent/WO2005102247A2/de not_active Ceased
- 2005-04-15 UA UAA200611799A patent/UA83915C2/ru unknown
- 2005-04-15 ES ES05730867T patent/ES2348038T5/es not_active Expired - Lifetime
- 2005-04-15 US US11/578,771 patent/US8071577B2/en active Active
- 2005-04-15 AT AT05730867T patent/ATE473734T1/de active
- 2005-04-15 JP JP2007508800A patent/JP4908399B2/ja not_active Expired - Lifetime
- 2005-04-15 KR KR1020067021681A patent/KR20060134168A/ko not_active Ceased
- 2005-04-15 EA EA200601844A patent/EA010313B1/ru active Protection Beyond IP Right Term
- 2005-04-15 EP EP05730867.8A patent/EP1740163B2/de not_active Expired - Lifetime
- 2005-04-15 AU AU2005235418A patent/AU2005235418C1/en not_active Expired
- 2005-04-15 PL PL05730867T patent/PL1740163T5/pl unknown
- 2005-04-15 RS RS20100413A patent/RS51434B2/sr unknown
- 2005-04-15 CN CN2005800125561A patent/CN1946383B/zh not_active Expired - Lifetime
- 2005-04-15 SI SI200531115T patent/SI1740163T2/sl unknown
- 2005-04-15 PT PT05730867T patent/PT1740163E/pt unknown
- 2005-04-15 DE DE502005009904T patent/DE502005009904D1/de not_active Expired - Lifetime
- 2005-04-15 NZ NZ550417A patent/NZ550417A/en not_active IP Right Cessation
- 2005-04-20 AR ARP050101553A patent/AR048830A1/es not_active Application Discontinuation
- 2005-04-20 SV SV2005002090A patent/SV2006002090A/es active IP Right Grant
- 2005-04-20 GT GT200500093A patent/GT200500093A/es unknown
- 2005-04-20 PE PE2005000436A patent/PE20060308A1/es not_active Application Discontinuation
- 2005-04-20 UY UY28863A patent/UY28863A1/es not_active Application Discontinuation
- 2005-04-20 PA PA20058630901A patent/PA8630901A1/es unknown
2006
- 2006-10-05 IL IL178510A patent/IL178510A/en active IP Right Grant
- 2006-10-19 CR CR8695A patent/CR8695A/es unknown
- 2006-11-13 EC EC2006007000A patent/ECSP067000A/es unknown
- 2006-11-17 ZA ZA2006/09594A patent/ZA200609594B/en unknown
- 2006-11-17 NO NO20065292A patent/NO344098B1/no unknown
2010
- 2010-03-18 US US12/726,799 patent/US20100173877A1/en not_active Abandoned
- 2010-10-14 CY CY20101100913T patent/CY1111292T1/el unknown
2011
- 2011-02-04 US US13/020,913 patent/US20110124612A1/en not_active Abandoned
- 2011-12-12 AR ARP110104615A patent/AR084229A2/es not_active Application Discontinuation
2015
- 2015-07-09 IL IL239861A patent/IL239861A0/en unknown

Also Published As

Publication number	Publication date
SI1740163T1 (sl)	2010-11-30
TW200534860A (en)	2005-11-01
AR048830A1 (es)	2006-05-31
AU2005235418B2 (en)	2009-08-06
RS51434B2 (sr)	2020-11-30
ES2348038T5 (es)	2020-09-14
GT200500093A (es)	2006-04-17
CN1946383A (zh)	2007-04-11
PE20060308A1 (es)	2006-05-25
BRPI0510005A (pt)	2007-09-18
EP1740163B2 (de)	2020-01-15
HRP20100513T1 (hr)	2010-11-30
PL1740163T5 (pl)	2020-10-05
CN1946383B (zh)	2010-06-09
UA83915C2 (ru)	2008-08-26
WO2005102247A3 (de)	2006-01-12
AU2005235418A1 (en)	2005-11-03
IL239861A0 (en)	2015-08-31
US20070259840A1 (en)	2007-11-08
ES2348038T3 (es)	2010-11-29
HRP20100513T4 (hr)	2020-10-02
EA010313B1 (ru)	2008-08-29
PL1740163T3 (pl)	2010-12-31
SV2006002090A (es)	2006-02-15
SI1740163T2 (sl)	2020-04-30
MY143669A (en)	2011-06-30
CA2561839A1 (en)	2005-11-03
NZ550417A (en)	2010-01-29
KR20060134168A (ko)	2006-12-27
CR8695A (es)	2008-07-29
ME01183B (me)	2013-03-20
WO2005102247A2 (de)	2005-11-03
JP4908399B2 (ja)	2012-04-04
RS51434B (sr)	2011-04-30
CY1111292T1 (el)	2015-08-05
ECSP067000A (es)	2006-12-29
NO344098B1 (no)	2019-09-02
DK1740163T4 (da)	2020-04-06
ZA200609594B (en)	2008-04-30
EA200601844A1 (ru)	2007-04-27
CA2561839C (en)	2009-09-29
US20110124612A1 (en)	2011-05-26
DE102004019743B4 (de)	2008-11-27
PT1740163E (pt)	2010-09-28
TWI351960B (en)	2011-11-11
DE502005009904D1 (de)	2010-08-26
IL178510A (en)	2015-08-31
JP2007533681A (ja)	2007-11-22
MXPA06012213A (es)	2007-01-17
DE102004019743A1 (de)	2005-11-24
US20100173877A1 (en)	2010-07-08
PA8630901A1 (es)	2006-05-16
HK1099701A1 (zh)	2007-08-24
US8071577B2 (en)	2011-12-06
EP1740163B1 (de)	2010-07-14
AR084229A2 (es)	2013-05-02
EP1740163A2 (de)	2007-01-10
UY28863A1 (es)	2005-11-30
ATE473734T1 (de)	2010-07-15
IL178510A0 (en)	2007-02-11
AU2005235418C1 (en)	2015-05-21
NO20065292L (no)	2007-01-17

Publication	Publication Date	Title
DK1737461T3 (da)	2013-03-18	Carbolin-derivater til inhibering af angiogenese
FI20040156A0 (fi)	2004-02-02	Hydraulivasara
DK1917923T3 (da)	2014-02-03	Indretning til omskæring af en penis
ATE425357T1 (de)	2009-03-15	Freistromturbinenanlage
DK1992697T3 (da)	2010-05-17	Fremstilling af TNFR-Fc
DK1575416T3 (da)	2014-01-13	Fremgangsmåder til diagnosticering af præeklampsi
DK4233792T3 (da)	2024-08-26	Indretning til krympning af klapproteser
DE112005001370T5 (de)	2007-05-16	Verzweigte Biodiesel
DK1677214T3 (da)	2014-05-19	Udvideligt filsystem
EP1734451A4 (en)	2009-09-16	FILE NAME GENERATION UNIT
DK1828164T3 (da)	2008-12-08	Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK2054428T3 (da)	2013-08-26	Udvikling af bestanddele til denque-virus-vaccine
ATE415385T1 (de)	2008-12-15	Hexafluorisopropanolsubstituierte etherderivate
IL239861A0 (en)	2015-08-31	A multi-phase birth control preparation based on natural estrogen
FI20045026L (fi)	2005-08-04	Kytkinlaite
FI20040067L (fi)	2005-07-20	Kytkinlaite
ITMI20041763A1 (it)	2004-12-16	Nuove formulazioni iniettabili contenenti progesterone
DK1727782T3 (da)	2012-10-08	Fremgangsmåde til fremstilling af aminophenolforbindelser
DK1725410T3 (da)	2014-09-22	Hæfte til arkivering af dokumenter
DK1831223T3 (da)	2013-06-10	Fremgangsmåde til fremstilling af L-biopterin
DK1834528T3 (da)	2014-07-14	Fremgangsmåde til fremstilling af gelé-agtige drikke
FI20040068L (fi)	2005-07-20	Kytkinlaite
DK1784183T3 (da)	2012-04-02	Fremgangsmåder til fremstilling af isothiazolderivater
DE602005020733D1 (de)	2010-06-02	Synchrone Steuervorrichtung
DE602005016039D1 (de)	2009-10-01	Synchrone Regeleinrichtung